Cheryl Ho

Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1–Selected Advanced Non–Small-Cell Lung Cancer (BIRCH)

Solange Peters, Scott Gettinger, Melissa L. Johnson et al. · Journal of Clinical Oncology · 2017 · 415 citations · Full text

Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non–Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Study

Glenwood Goss, Andrew Arnold, Frances A. Shepherd et al. · Journal of Clinical Oncology · 2009 · 243 citations

Advanced Nsclc, Medicine, Phase Iii +12

EGFR mutation status on brain metastases from non-small cell lung cancer

Fred Hsu, Alex De Caluwé, David W. Anderson et al. · Lung Cancer · 2016 · 133 citations

Neuro-oncology, Brain Metastases, Pathology +6

ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results

Valsamo Anagnostou, Cheryl Ho, Garth Nicholas et al. · Nature Medicine · 2023 · 125 citations · Full text

Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers

Janessa Laskin, Steven J.M. Jones, Samuel Aparício et al. · Molecular Case Studies · 2015 · 112 citations · Full text

Engineering, Pathology, Multiomics +18